UA102083C2 - Стабильная кристаллическая соль 1-азабицикло[2.2.2]окт-3-илового сложного эфира (r)-3-фторфенил-3,4,5-трифторбензилкарбаминовой кислоты - Google Patents

Стабильная кристаллическая соль 1-азабицикло[2.2.2]окт-3-илового сложного эфира (r)-3-фторфенил-3,4,5-трифторбензилкарбаминовой кислоты

Info

Publication number
UA102083C2
UA102083C2 UAA201007997A UAA201007997A UA102083C2 UA 102083 C2 UA102083 C2 UA 102083C2 UA A201007997 A UAA201007997 A UA A201007997A UA A201007997 A UAA201007997 A UA A201007997A UA 102083 C2 UA102083 C2 UA 102083C2
Authority
UA
Ukraine
Prior art keywords
azabicyclo
fluorophenyl
oct
ester
crystalline salt
Prior art date
Application number
UAA201007997A
Other languages
English (en)
Ukrainian (uk)
Inventor
Руіс Хуан Лоренсо Катена
Родрігес Хосе Ідальго
Комас Марія дель Кармен Серра
Масіп Ісабель Масіп
Original Assignee
Лабораторіос Салват, С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лабораторіос Салват, С.А. filed Critical Лабораторіос Салват, С.А.
Publication of UA102083C2 publication Critical patent/UA102083C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Данное изобретение касается стабильной кристаллической D-тартратной соли 1-азабицикло[2.2.2]окт-3-илового сложного эфира (R)-3-фторфенил-3,4,5-трифторбензилкарбаминовой кислоты формулы (I) и ее применения как лекарственного средства, в частности для лечения недержания мочи и других заболеваний, связанных с мочеполовыми расстройствами. EMBED ISISServer (I).
UAA201007997A 2007-11-28 2008-11-26 Стабильная кристаллическая соль 1-азабицикло[2.2.2]окт-3-илового сложного эфира (r)-3-фторфенил-3,4,5-трифторбензилкарбаминовой кислоты UA102083C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07384038A EP2065385A1 (en) 2007-11-28 2007-11-28 Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester
PCT/EP2008/010012 WO2009068253A2 (en) 2007-11-28 2008-11-26 Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-yl ester

Publications (1)

Publication Number Publication Date
UA102083C2 true UA102083C2 (ru) 2013-06-10

Family

ID=39401152

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201007997A UA102083C2 (ru) 2007-11-28 2008-11-26 Стабильная кристаллическая соль 1-азабицикло[2.2.2]окт-3-илового сложного эфира (r)-3-фторфенил-3,4,5-трифторбензилкарбаминовой кислоты

Country Status (19)

Country Link
US (2) US8492402B2 (ru)
EP (2) EP2065385A1 (ru)
JP (1) JP5336509B2 (ru)
KR (1) KR101557832B1 (ru)
CN (1) CN101925600B (ru)
AU (1) AU2008329181B2 (ru)
BR (1) BRPI0819607A2 (ru)
CA (1) CA2706565C (ru)
DK (1) DK2220082T3 (ru)
EA (1) EA017483B1 (ru)
ES (1) ES2498819T3 (ru)
HK (1) HK1144192A1 (ru)
IL (1) IL206032A (ru)
MX (1) MX2010005850A (ru)
NZ (1) NZ585833A (ru)
PL (1) PL2220082T3 (ru)
UA (1) UA102083C2 (ru)
WO (1) WO2009068253A2 (ru)
ZA (1) ZA201003718B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1345937T3 (da) 2000-12-22 2006-01-16 Almirall Prodesfarma Ag Quinuclidincarbamatderivater og deres anvendelse som M3-antagonister
PT3150610T (pt) 2010-02-12 2019-11-11 Pfizer Sais e polrmorfos de 8-fluor0-2-{4- [(metilamino}metil]fenil}-1,3,4,5-tetrahidr0-6hazepin0[ 5,4,3-cd]indol-6-0na
KR101978364B1 (ko) 2017-06-15 2019-05-14 크리스탈지노믹스(주) 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 또는 그 유도체의 약학적으로 허용 가능한 염 및 그 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE510305C2 (sv) * 1997-05-30 1999-05-10 Astra Ab Nytt salt
PT1300407E (pt) * 2000-06-27 2004-05-31 S A L V A T Lab Sa Compostos carbamatos derivados de arilalquilaminas
DK1345937T3 (da) * 2000-12-22 2006-01-16 Almirall Prodesfarma Ag Quinuclidincarbamatderivater og deres anvendelse som M3-antagonister
US7452904B2 (en) 2001-12-20 2008-11-18 Chiesi Farmaceutici S.P.A. 1-alkyl-1-azoniabicyclo' 2.2.2 octane carbamate derivatives and their use as muscarinic receptor antagonists
ES2203327B1 (es) * 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
ES2246170B1 (es) * 2004-07-29 2007-04-01 Almirall Prodesfarma, S.A. Nuevo procedimiento para preparar derivados de carbamato de quinuclidinio.

Also Published As

Publication number Publication date
US20110207769A1 (en) 2011-08-25
PL2220082T3 (pl) 2014-12-31
KR20100103532A (ko) 2010-09-27
CN101925600B (zh) 2013-01-09
EA017483B1 (ru) 2012-12-28
IL206032A0 (en) 2010-11-30
US8871787B2 (en) 2014-10-28
CA2706565C (en) 2015-04-28
DK2220082T3 (da) 2014-10-06
IL206032A (en) 2014-07-31
EA201070651A1 (ru) 2010-12-30
WO2009068253A2 (en) 2009-06-04
US20140051721A1 (en) 2014-02-20
BRPI0819607A2 (pt) 2015-10-13
AU2008329181A1 (en) 2009-06-04
CN101925600A (zh) 2010-12-22
US8492402B2 (en) 2013-07-23
AU2008329181B2 (en) 2012-03-29
JP2011504890A (ja) 2011-02-17
EP2220082B1 (en) 2014-06-25
ES2498819T3 (es) 2014-09-25
CA2706565A1 (en) 2009-06-04
MX2010005850A (es) 2010-09-03
ZA201003718B (en) 2011-08-31
NZ585833A (en) 2011-05-27
EP2065385A1 (en) 2009-06-03
WO2009068253A3 (en) 2009-08-13
EP2220082A2 (en) 2010-08-25
HK1144192A1 (en) 2011-02-02
KR101557832B1 (ko) 2015-10-06
JP5336509B2 (ja) 2013-11-06

Similar Documents

Publication Publication Date Title
MX2009012163A (es) Hetarilanilinas como moduladores para beta-amiloide.
WO2011058474A8 (en) N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
MX2009006756A (es) Derivados de 1-amino-metil-l-fenil-ciclohexano como inhibidores de dpp-iv.
WO2010141796A3 (en) PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVES
JO2751B1 (en) Imidazoleens as lipid kinase inhibitors
WO2009127669A3 (en) Ido inhibitors and therapeutic uses thereof
WO2008116129A3 (en) Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors
WO2012016186A8 (en) Macrocyclic kinase inhibitors and uses thereof
SG151260A1 (en) 5-substituted-2-phenylamino-benzamides as mek inhibitors
GEP20146100B (en) Novel phenylimidazole derivative as pde10a enzyme inhibitor
EP2639229A3 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
WO2008137816A8 (en) Tricyclic compounds as matrix metalloproteinase inhibitors
MX2009005413A (es) Formas cristalinas del acido zoledronico.
AU2016219650A1 (en) Compositions and methods for extended therapy with aminopyridines
WO2006116733A3 (en) Protein kinase inhibitors
MX2011009709A (es) Compuestos para el tratamiento de la inflamacion y del dolor.
MY173491A (en) Therapeutic or prophylactic agent for biliary tract diseases
SG141358A1 (en) Treatment of psychiatric patients with reduced heptaic function with paliperidone
WO2008071961A8 (en) 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents
UA102083C2 (ru) Стабильная кристаллическая соль 1-азабицикло[2.2.2]окт-3-илового сложного эфира (r)-3-фторфенил-3,4,5-трифторбензилкарбаминовой кислоты
GEP20125570B (en) Use of indazolemethoxyalkanoic acid for reducing levels of triglycerides, cholesterol and glucose
WO2011047055A8 (en) Novel mek inhibitors, useful in the treatment of diseases
TW200833708A (en) Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
WO2011000945A3 (en) Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns